Your browser doesn't support javascript.
loading
Improved models of care for cancer survivors.
Jefford, Michael; Howell, Doris; Li, Qiuping; Lisy, Karolina; Maher, Jane; Alfano, Catherine M; Rynderman, Meg; Emery, Jon.
Afiliación
  • Jefford M; Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. Electroni
  • Howell D; Princess Margaret Cancer Research Institute, Toronto, ON, Canada.
  • Li Q; Wuxi School of Medicine, Jiangnan University, Wuxi, China.
  • Lisy K; Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Maher J; Macmillan Cancer Support, London, UK.
  • Alfano CM; Northwell Health Cancer Institute, Lake Success, NY, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
  • Rynderman M; Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Emery J; Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
Lancet ; 399(10334): 1551-1560, 2022 04 16.
Article en En | MEDLINE | ID: mdl-35430022
ABSTRACT
The number of survivors of cancer is increasing substantially. Current models of care are unsustainable and fail to address the many unmet needs of survivors of cancer. Numerous trials have investigated alternate models of care, including models led by primary-care providers, care shared between oncology specialists and primary-care providers, and care led by oncology nurses. These alternate models appear to be at least as effective as specialist-led care and are applicable to many survivors of cancer. Choosing the most appropriate care model for each patient depends on patient-level factors (such as risk of longer-term effects, late effects, individual desire, and capacity to self-manage), local services, and health-care policy. Wider implementation of alternative models requires appropriate support for non-oncologist care providers and endorsement of these models by cancer teams with their patients. The COVID-19 pandemic has driven some changes in practice that are more patient-centred and should continue. Improved models should shift from a predominant focus on detection of cancer recurrence and seek to improve the quality of life, functional outcomes, experience, and survival of survivors of cancer, reduce the risk of recurrence and new cancers, improve the management of comorbidities, and reduce costs to patients and payers. This Series paper focuses primarily on high-income countries, where most data have been derived. However, future research should consider the applicability of these models in a wider range of health-care settings and for a wider range of cancers.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Supervivientes de Cáncer / COVID-19 / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Supervivientes de Cáncer / COVID-19 / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Año: 2022 Tipo del documento: Article